Skip to main content Accessibility help
×
Home
  • Print publication year: 2011
  • Online publication date: August 2011

10 - Restless legs syndrome and sleep-related disorders

References

1. Willis T. De anima brutorum. London: Wells & Scott; 1672.
2. Ekbom KA. Restless legs syndrome. Acta Med Scand 1945; 158(Suppl.): 4–124.
3. Nordlander NB. Therapy in restless legs. Acta Med Scand 1953; 145(6): 453–57.
4. Lin SC, Kaplan J, Burger CD, Fredrickson PA. Effect of pramipexole in treatment of resistant restless legs syndrome. Mayo Clin Proc 1998; 73(6): 497–500.
5. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995; 10(5): 634–42.
6. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4(2): 101–19.
7. International Classification of Sleep Disorders. American Academy of Sleep Medicine. Diagnostic and Coding Manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005: 1–208.
8. Terzano MG, Parrino L, Cirignotta F et al. Studio Morfeo: insomnia in primary care, a survey conducted on the Italian population. Sleep Med 2004; 5(1): 67–75.
9. Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol 2005; 4(8): 465–75.
10. Michaud M, Lavigne G, Desautels A, Poirier G, Montplaisir J. Effects of immobility on sensory and motor symptoms of restless legs syndrome. Mov Disord 2002; 17(1): 112–15.
11. Trenkwalder C, Hening WA, Walters AS, Campbell SS, Rahman K, Chokroverty S. Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome. Mov Disord 1999; 14(1): 102–10.
12. Trenkwalder C. Restless legs syndrome: overdiagnosed or underdiagnosed? Nat Clin Pract Neurol 2007; 3(9): 474–5.
13. Cho YW, Shin WC, Yun CH et al. Epidemiology of restless legs syndrome in Korean adults. Sleep 2008; 31(2): 219–23.
14. Rijsman R, Neven AK, Graffelman W, Kemp B, de Weerd A. Epidemiology of restless legs in The Netherlands. Eur J Neurol 2004; 11(9): 607–11.
15. Tison F, Crochard A, Leger D, Bouee S, Lainey E, El Hasnaoui A. Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study. Neurology 2005; 65(2): 239–46.
16. Van De Vijver DA, Walley T, Petri H. Epidemiology of restless legs syndrome as diagnosed in UK primary care. Sleep Med 2004; 5(5): 435–40.
17. Ziaei J, Saadatnia M. Epidemiology of familial and sporadic restless legs syndrome in Iran. Arch Iran Med 2006; 9(1): 65–7.
18. Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 2006; 10(3): 153–67.
19. Trenkwalder C, Hogl B, Winkelmann J. Recent advances in the diagnosis, genetics and treatment of restless legs syndrome. J Neurol 2009; 256(4): 539–53.
20. Allen RP, Walters AS, Montplaisir J et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005; 165(11): 1286–92.
21. Whittom S, Dauvilliers Y, Pennestri MH et al. Age-at-onset in restless legs syndrome: a clinical and polysomnographic study. Sleep Med 2007; 9(1): 54–9.
22. Hanson M, Honour M, Singleton A, Crawley A, Hardy J, Gwinn-Hardy K. Analysis of familial and sporadic restless legs syndrome in age of onset, gender, and severity features. J Neurol 2004; 251(11): 1398–401.
23. Hornyak M. Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management. CNS Drugs 2010; 24(2): 89–98.
24. Cuellar NG, Strumpf NE, Ratcliffe SJ. Symptoms of restless legs syndrome in older adults: outcomes on sleep quality, sleepiness, fatigue, depression, and quality of life. J Am Geriatr Soc 2007; 55(9): 1387–92.
25. Mallon L, Broman JE, Hetta J. Restless legs symptoms with sleepiness in relation to mortality: 20-year follow-up study of a middle-aged Swedish population. Psychiatry Clin Neurosci 2008; 62(4): 457–63.
26. Kallweit U, Siccoli MM, Poryazova R, Werth E, Bassetti CL. Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment. Eur Neurol 2009; 62(3): 176–9.
27. Ramchandren S, Chervin RD. The relationship between restless legs syndrome and neuropathy. Mov Disord 2007; 22(4): 588; author reply 9.
28. Gemignani F, Marbini A. Restless legs syndrome and peripheral neuropathy. J Neurol Neurosurg Psychiatry 2002; 72(4): 555.
29. Gemignani F, Marbini A, Di Giovanni G et al. Cryoglobulinaemic neuropathy manifesting with restless legs syndrome. J Neurol Sci 1997; 152(2): 218–23.
30. Iannaccone S, Zucconi M, Marchettini P et al. Evidence of peripheral axonal neuropathy in primary restless legs syndrome. Mov Disord 1995; 10(1): 2–9.
31. Callaghan N. Restless legs syndrome in uremic neuropathy. Neurology 1966; 16(4): 359–61.
32. Rijsman RM, de Weerd AW. Secondary periodic limb movement disorder and restless legs syndrome. Sleep Med Rev 1999; 3(2): 147–58.
33. Bartell S, Zallek S. Intravenous magnesium sulfate may relieve restless legs syndrome in pregnancy. J Clin Sleep Med 2006; 2(2): 187–8.
34. Hornyak M, Voderholzer U, Hohagen F, Berger M, Riemann D. Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study. Sleep 1998; 21(5): 501–5.
35. Gemignani F. A further cause of secondary restless legs syndrome: Crohn’s disease. Inflamm Bowel Dis 2010; 16(2): 280–1.
36. Weinstock LB, Bosworth BP, Scherl EJ et al. Crohn’s disease is associated with restless legs syndrome. Inflamm Bowel Dis 2010; 16(2): 275–9.
37. Ondo W, Tan EK, Mansoor J. Rheumatologic serologies in secondary restless legs syndrome. Mov Disord 2000; 15(2): 321–3.
38. Enomoto M, Inoue Y, Namba K, Munezawa T, Matsuura M. Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients. Mov Disord 2008; 23(6): 811–6; quiz 926.
39. Manconi M, Ferini-Strambi L, Filippi M et al. Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. Sleep 2008; 31(7): 944–52.
40. Manconi M, Rocca MA, Ferini-Strambi L et al. Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage. Mult Scler 2008; 14(1): 6–93.
41. Gemignani F, Brindani F, Vitetta F, Marbini A, Calzetti S. Restless legs syndrome in diabetic neuropathy: a frequent manifestation of small fiber neuropathy. J Peripher Nerv Syst 2007; 12(1): 50–3.
42. Polydefkis M, Allen RP, Hauer P, Earley CJ, Griffin JW, McArthur JC. Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology 2000; 55(8): 1115–21.
43. Walters AS, LeBrocq C, Dhar A et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003; 4(2): 121–32.
44. Wunderlich GR, Evans KR, Sills T et al. An item response analysis of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med 2005; 6(2): 131–9.
45. Abetz L, Vallow SM, Kirsch J, Allen RP, Washburn T, Earley CJ. Validation of the Restless Legs Syndrome Quality of Life questionnaire. Value Health 2005; 8(2): 157–67.
46. Atkinson MJ, Allen RP, DuChane J, Murray C, Kushida C, Roth T. Validation of the Restless Legs Syndrome Quality of Life Instrument (RLS-QLI): findings of a consortium of national experts and the RLS Foundation. Qual Life Res 2004; 13(3): 679–93.
47. Ferri R, Lanuzza B, Cosentino FI et al. A single question for the rapid screening of restless legs syndrome in the neurological clinical practice. Eur J Neurol 2007; 14(9): 1016–21.
48. Stiasny-Kolster K, Kohnen R, Moller JC, Trenkwalder C, Oertel WH. Validation of the “L-DOPA test” for diagnosis of restless legs syndrome. Mov Disord 2006; 21(9): 1333–9.
49. Coccagna G, Lugaresi E. Restless legs syndrome and nocturnal myoclonus. Int J Neurol 1981; 15(1–2): 77–87.
50. Lugaresi E, Cirignotta F, Coccagna G, Montagna P. Nocturnal myoclonus and restless legs syndrome. Adv Neurol 1986; 43: 295–307.
51.EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992; 15(2): 173–84.
52. Zucconi M, Ferri R, Allen R et al. The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG). Sleep Med 2006; 7(2): 175–83.
53. Parrino L, Boselli M, Buccino GP, Spaggiari MC, Di Giovanni G, Terzano MG. The cyclic alternating pattern plays a gate-control on periodic limb movements during non-rapid eye movement sleep. J Clin Neurophysiol 1996; 13(4): 314–23.
54. Chabli A, Michaud M, Montplaisir J. Periodic arm movements in patients with the restless legs syndrome. Eur Neurol 2000; 44(3): 133–8.
55. Hornyak M, Feige B, Riemann D, Voderholzer U. Periodic leg movements in sleep and periodic limb movement disorder: prevalence, clinical significance and treatment. Sleep Med Rev 2006; 10(3): 169–77.
56. Drigo R, Fontana M, Coin A, Ferraresso A, Enzo E, Zambotto FM. APAP titration in patients with mild to moderate OSAS and periodic limb movement syndrome. Monaldi Arch Chest Dis 2006; 65(4): 196–203.
57. Poewe W, Hogl B. Akathisia, restless legs and periodic limb movements in sleep in Parkinson’s disease. Neurology 2004; 63(8 Suppl 3): S12–6.
58. Spillane JD, Nathan PW, Kelly RE, Marsden CD. Painful legs and moving toes. Brain 1971; 94(3): 541–56.
59. Lee JE, Shin HW, Kim KS, Sohn YH. Factors contributing to the development of restless legs syndrome in patients with Parkinson disease. Mov Disord 2009; 24(4): 579–82.
60. Tribl GG, Asenbaum S, Klosch G et al. Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome. Neurology 2002; 59(4): 649–50.
61. Eisensehr I, Wetter TC, Linke R et al. Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology 2001; 57(7): 1307–9.
62. Schmidauer C, Sojer M, Seppi K et al. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol 2005; 58(4): 630–4.
63. Connor JR, Boyer PJ, Menzies SL et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003; 61(3): 304–9.
64. Moller JC, Unger M, Stiasny-Kolster K, Oertel WH. Restless Legs Syndrome (RLS) and Parkinson’s disease (PD)-related disorders or different entities? J Neurol Sci 289(1–2): 135–7.
65. Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002; 59(3): 421–4.
66. Kedia S, Moro E, Tagliati M, Lang AE, Kumar R. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease. Neurology. 2004; 63(12): 2410–2.
67. Goodman JD, Brodie C, Ayida GA. Restless leg syndrome in pregnancy. BMJ 1988; 297(6656): 1101–2.
68. Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 1996; 28(3): 372–8.
69. de Mello MT, Lauro FA, Silva AC, Tufik S. Incidence of periodic leg movements and of the restless legs syndrome during sleep following acute physical activity in spinal cord injury subjects. Spinal Cord 1996; 34(5): 294–6.
70. Manconi M, Govoni V, De Vito A et al. Pregnancy as a risk factor for restless legs syndrome. Sleep Med 2004; 5(3): 305–8.
71. Manconi M, Govoni V, De Vito A et al. Restless legs syndrome and pregnancy. Neurology 2004; 63(6): 1065–9.
72. Molnar MZ, Novak M, Ambrus C et al. Restless Legs Syndrome in patients after renal transplantation. Am J Kidney Dis 2005; 45(2): 388–96.
73. Winkelmann J, Stautner A, Samtleben W, Trenkwalder C. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord 2002; 17(5): 1072–6.
74. Larsson BW, Kadi F, Ulfberg J, Aulin KP. Skeletal muscle morphology in patients with restless legs syndrome. Eur Neurol 2007; 58(3): 133–7.
75. Hanna PA, Kumar S, Walters AS. Restless legs symptoms in a patient with above knee amputations: a case of phantom restless legs. Clin Neuropharmacol 2004; 27(2): 87–9.
76. Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 2004; 5(3): 237–46.
77. Kushida C, Martin M, Nikam P et al. Burden of restless legs syndrome on health-related quality of life. Qual Life Res 2007; 16(4): 617–24.
78. Abetz L, Allen R, Follet A et al. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther 2004; 26(6): 925–35.
79. Michaud M. Is the suggested immobilization test the “gold standard” to assess restless legs syndrome? Sleep Med 2006; 7(7): 541–3.
80. Michaud M, Poirier G, Lavigne G, Montplaisir J. Restless legs syndrome: scoring criteria for leg movements recorded during the suggested immobilization test. Sleep Med 2001; 2(4): 317–21.
81. Montplaisir J, Boucher S, Nicolas A et al. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome. Mov Disord 1998; 13(2): 324–9.
82. Hornyak M, Kotterba S, Trendwalder C. Consensus statement from the German Sleep Society: indications for performing polysomnography in the diagnosis and treatment of restless leg syndrome. Sleep Med 2002; 3(5): 457–8.
83. Hornyak M, Feige B, Voderholzer U, Philipsen A, Riemann D. Polysomnography findings in patients with restless legs syndrome and in healthy controls: a comparative observational study. Sleep 2007; 30(7): 861–5.
84. Lichstein KL, Stone KC, Donaldson J et al. Actigraphy validation with insomnia. Sleep 2006; 29(2): 232–9.
85. Allen RP. Improving RLS diagnosis and severity assessment: polysomnography, actigraphy and RLS-sleep log. Sleep Med 2007; 8(Suppl 2): S13–8.
86. Ferini-Strambi L, Bonati MT, Oldani A, Aridon P, Zucconi M, Casari G. Genetics in restless legs syndrome. Sleep Med 2004; 5(3): 301–4.
87. Allen RP, Earley CJ. Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset. Sleep Med 2000; 1(1): 11–9.
88. Allen RP. Article reviewed: Restless legs syndrome in monozygotic twins: clinical correlates. Sleep Med 2001; 2(2): 169–71.
89. Ondo WG, Vuong KD, Wang Q. Restless legs syndrome in monozygotic twins: clinical correlates. Neurology 2000; 55(9): 1404–6.
90. Gubitz AK, Gwinn K. Mining the genome for susceptibility to complex neurological disorders. Curr Mol Med 2009; 9(7): 801–13.
91. Caylak E. The genetics of sleep disorders in humans: narcolepsy, restless legs syndrome, and obstructive sleep apnea syndrome. Am J Med Genet A 2009; 149A(11): 2612–26.
92. Pittock SJ, Parrett T, Adler CH, Parisi JE, Dickson DW, Ahlskog JE. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. Mov Disord 2004; 19(6): 695–9.
93. Cervenka S, Palhagen SE, Comley RA et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain 2006; 129(Pt 8): 2017–28.
94. Ruottinen HM, Partinen M, Hublin C et al. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology 2000; 54(2): 502–4.
95. Turjanski N, Lees AJ, Brooks DJ. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 1999; 52(5): 932–7.
96. Ondo WG, He Y, Rajasekaran S, Le WD. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord 2000; 15(1): 154–8.
97. Matthews WB. Letter: Iron deficiency and restless legs. Br Med J 1976; 1(6014): 898.
98. Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 2005; 14(1): 43–7.
99. Mahowald MW. Restless legs syndrome: the CNS/iron connection. J Lab Clin Med 2006; 147(2): 56–7.
100. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000; 54(8): 1698–700.
101. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001; 56(2): 263–5.
102. Haba-Rubio J, Staner L, Petiau C, Erb G, Schunck T, Macher JP. Restless legs syndrome and low brain iron levels in patients with haemochromatosis. J Neurol Neurosurg Psychiatry 2005; 76(7): 1009–10.
103. Paulus W, Trenkwalder C. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol 2006; 5(10): 878–86.
104. Happe S, Vennemann M, Evers S, Berger K. Treatment of individuals with known and unknown restless legs syndrome in the community. J Neurol 2008; 255(9): 1365–71.
105. Hening WA. Current guidelines and standards of practice for restless legs syndrome. Am J Med 2007; 120(1 Suppl 1): S22–7.
106. Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996; 19(3): 205–13.
107. McLean AJ. The use of the dopamine-receptor partial agonist aripiprazole in the treatment of restless legs syndrome. Sleep 2004; 27(5): 1022.
108. Stiasny-Kolster K, Kohnen R, Schollmayer E, Moller JC, Oertel WH. Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study. Mov Disord 2004; 19(12): 1432–8.
109. Porter MC, Appiah-Kubf LS, Chaudhuri KR. Treatment of Parkinson’s disease and restless legs syndrome with cabergoline, a long-acting dopamine agonist. Int J Clin Pract 2002; 56(6): 468–74.
110. Tergau F, Wischer S, Wolf C, Paulus W. Treatment of restless legs syndrome with the dopamine agonist alpha-dihydroergocryptine. Mov Disord 2001; 16(4): 731–5.
111. Kruszewski SP, Shane J. Efficacy and safety of pramipexole in restless legs syndrome. Neurology 2007; 68(19): 1641; author reply 2.
112. McCormack PL, Siddiqui MA. Pramipexole: in restless legs syndrome. CNS Drugs 2007; 21(5): 429–37; discussion 38–40.
113. Partinen M, Hirvonen K, JAMA L et al. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study – the PRELUDE study. Sleep Med 2006; 7(5): 407–17.
114. Horvath J, Fross RD, Kleiner-Fisman G et al. Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists. Mov Disord 2004; 19(6): 656–62.
115. Vignatelli L, Billiard M, Clarenbach P et al. EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep. Eur J Neurol 2006; 13(10): 1049–65.
116. Garcia-Borreguero D, Allen RP, Benes H et al. Augmentation as a treatment complication of restless legs syndrome: concept and management. Mov Disord 2007; 22(Suppl 18): S476–84.
117. Garcia-Borreguero D, Kohnen R, Hogl B et al. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome. Sleep Med 2007; 8(5): 455–63.
118. Larsen S, Telstad W, Sorensen O, Thom E, Stensrud P, Nyberg-Hansen R. Carbamazepine therapy in restless legs. Discrimination between responders and non-responders. Acta Med Scand 1985; 218(2): 223–7.
119. Eisensehr I, Ehrenberg BL, Rogge Solti S, Noachtar S. Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid. J Neurol 2004; 251(5): 579–83.
120. Youssef EA, Wagner ML, Martinez JO, Hening W. Pilot trial of lamotrigine in the restless legs syndrome. Sleep Med 2005; 6(1): 89.
121. Della Marca G, Vollono C, Mariotti P et al. Levetiracetam can be effective in the treatment of restless legs syndrome with periodic limb movements in sleep: report of two cases. J Neurol Neurosurg Psychiatry 2006; 77(4): 566–7.
122. Albanese A, Filippini G. Gabapentin improved sensory and motor symptoms in the restless legs syndrome. ACP J Club 2003; 139(1): 17.
123. Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 2002; 59(10): 1573–9.
124. Boghen D, Lamothe L, Elie R, Godbout R, Montplaisir J. The treatment of the restless legs syndrome with clonazepam: a prospective controlled study. Can J Neurol Sci 1986; 13(3): 245–7.
125. Walters AS, Wagner ML, Hening WA et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993; 16(4): 327–32.
126. Ondo WG. Methadone for refractory restless legs syndrome. Mov Disord 2005; 20(3): 345–8.
127. Lindvall P, Ruuth K, Jakobsson B, Nilsson S. Intrathecal morphine as a treatment for refractory restless legs syndrome. Neurosurgery 2008; 63(6): E1209; author reply E1209.
128. Lauerma H, Markkula J. Treatment of restless legs syndrome with tramadol: an open study. J Clin Psychiatry 1999; 60(4): 241–4.